Our customers have always known that they can depend on MSD Animal Health for more than just medicines. They count on MSD Animal Health for information, technologies and veterinary services that truly advance animal healthcare. It is our heritage and our mission.
The Science of Healthier Animals
Today, our science supports the precious bond between people and their pets. It also helps protect international public health, ensure food safety and increase protein supplies.
Today, our science supports the precious bond between people and their pets. It also helps protect international public health, ensure food safety and increase protein supplies.
RESPONSIBLE
Appreciating the fundamental role of progressive science in animal health, understanding the deep responsibility MSD Animal Health has to our customers, consumers, animals, society and the planet.
VISIONARY
Being original in thought and approach, having the confidence and determination to come up and work with new insights, greater understanding and fresh knowledge.
COLLABORATIVE
Working closely, sharing understanding and inspiring one another and customers, allowing science and thinking to flourish, enabling the right balance of cost against human capability.
DYNAMIC
Aiming at being efficient, fast and flexible in all operations, responding rapidly to new opportunities and demands, an outward orientated performance culture that values talent and action.
Our People
Bringing our purpose to life.
“Animal welfare is so fundamental to everything that veterinarians do, that we as employees do, and to all that our company does.”
Dr. Angela Baysinger, Animal Welfare Lead, North America
“In any organization, it’s important that we have diversity, because it not only brings diversity of thought, but it also brings diversity to our processes.”
Scott Bormann, Senior Vice President, North America
MSD Animal Health has a rich heritage of scientific excellence and innovation. It is the foundation of our future and the inspiration for our daily work.
1940s
MSD establishes an animal health division and discovers sulfaquinoxaline, the first poultry coccidiostat.
1949
Feed manufacturer Wim Hendrix lays the foundation for Intervet in Boxmeer (The Netherlands), where the Animal health headquarters of todays’ company remained until 2012.
1950s
Schering-Plough Animal Health is established and comes to market with prednisone to treat ketosis in dairy cattle.
Intervet develops first fowl pox vaccine for poultry
1955
Publication of first edition of The MSD Veterinary Manual.
1961
Netherlands based “Koninklijke Zwanenburg Organon” (which later became AKZO NOBEL) acquires Intervet.
1970s
Introduction of anti-inflammatory drug for horses (Schering-Plough Animal Health).
Launch of products for reproduction management in farm animals (Intervet). Development of anthelmintic fenbendazole (Intervet).
1980s
Development of first recombinant DNA vaccine (PORCILIS® Porcoli against diarrhea in piglets) by Intervet.
1990s
Development of florfenicol, a novel phenicol antibiotics exclusive to animal health (Schering-Plough Animal Health).
Introduction of antiparasitic SCALIBOR® a dog collar to prevent Leishmaniasis from sand fly bites (Intervet)
1997
MSD and French pharmaceutical company Rhone-Merieux (later Sanofi) combine their animal health divisions in an equally-owned joint venture named Merial.
2000s
Launch of SLICE® fish antiparasitic for the treatment of seas lice in salmon (Schering-Plough Animal Health).
Licensure of the first live bacterial recombinant vaccine against strangles in horses in the EU (Intervet).
Introduction of PORCILIS® Pesti, the first marker vaccine for classical swine fever (Intervet)
2005
Harrisvaccines was founded in Iowa
2007
Schering-Plough acquires Organon Biosciences (Intervet and Organon) from AKZO NOBEL. The animal health division operates as Intervet/Schering-Plough Animal Health.
2009
Development of Sphereon, freeze-drying technology for vaccines (Intervet/Schering-Plough Animal Health).
Merck & Co., Inc., Kenilworth, NJ, USA acquires Schering-Plough. Intervet/Schering-Plough Animal Health becomes the animal health division of MSD.
2011
The operating name of the animal health unit changes to MSD Animal Health
2014
MSD Animal Health receives FDA approval of BRAVECTO™, the first chewable tablet for dogs for up to 12 weeks of treatment and prevention of fleas and ticks.
MSD Animal Health receives approval of PORCILIS® PCV M Hyo vaccine, Europe’s first single-shot vaccine to protect piglets from Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae infections
2015
MSD Animal Health receives a conditional product license for the Canine Influenza Vaccine H3N2 and becomes the first company to make the vaccine available to the market.
MSD Animal Health acquires Harrisvaccines, a privately-held company that develops, manufactures and sells vaccines for food production and companion animals
2016
MSD Animal Health receives marketing approval from European Medicines Agency and U.S. Food and Drug Administration’s approval of BRAVECTO® for both cats and dogs, up to 12 weeks of treatment and prevention of fleas and ticks.
MSD Animal Health receives approval for conditional product license for CIV H3N2 vaccine to protect dogs against the newly identified strain of CIV
We’ve achieved our reach through an absolute commitment to regional understanding. It helps us react quickly to changing disease landscapes around the world. We help protect public health and effectively address local concerns.
Featured Stories
Explore our archive of featured stories and learn more about how MSD Animal Health protects the health of animals.
